Mind Medicine, Inc. Completes over US$6 Million Non-Brokered Offering

November 25, 2019

Mind Medicine, Inc. (“MindMed”), a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering, has completed a non-brokered offering of 60,992,630 non-voting Class C Shares and Class D Shares at a price of US$0.10 per share for gross proceeds of US$6,099,263.

Wildeboer Dellelce LLP acted for MindMed in connection with the Offering with a team that consisted of Perry Dellelce, Peter Volk, Joel Fraser and Natalie Tershakowec (corporate/securities) and Katy Pitch (tax).